INNATE PHARMA (IPHYF) analyst actions
Rating and price-target actions on IPHYF in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the IPHYF overview →
No IPHYF analyst action events in the measured window.
Nothing matched in the current window — the IPHYF overview has every event we measure for this name.
Get an email when IPHYF moves on news →Keep exploring
More IPHYF: earnings → · SEC filings → · IPHYF overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ContextLogic Inc. (LOGC) | 132 | 0.00% | 40% |
| Champions Oncology, Inc. (CSBR) | 130 | +0.20% | 53% |
| Deciphera Pharmaceuticals, Inc. (DCPH) | 129 | +0.04% | 55% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 129 | -0.18% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.